We are live on ! Find out more
PASG icon

Passage Bio
PASG

99 hedge funds and large institutions have $278M invested in Passage Bio in 2021 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 41 increasing their positions, 22 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

86% more repeat investments, than reductions

Existing positions increased: 41 | Existing positions reduced: 22

30% more call options, than puts

Call options by funds: $90K | Put options by funds: $69K

0.15% more ownership

Funds ownership: 3.89% → 4.04% (+0.15%)

6% less first-time investments, than exits

New positions opened: 17 | Existing positions closed: 18

2% less funds holding

Funds holding: 101 → 99 (-2)

25% less funds holding in top 10

Funds holding in top 10: 4 → 3 (-1)

34% less capital invested

Capital invested by funds: $419M → $278M (-$142M)

Holders
99
Holders Change
-2
Holders Change %
-1.98%
% of All Funds
1.52%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.05%
New
17
Increased
41
Reduced
22
Closed
18
Calls
$90K
Puts
$69K
Net Calls
+$21K
Net Calls Change
+$190K

Top Buyers

1
WP
Woodline Partners
California
+$13M
2
GPP
Great Point Partners
Connecticut
+$12.4M
3
EAM
Erste Asset Management
Austria
+$4.37M
4
Morgan Stanley
Morgan Stanley
New York
+$3.34M
5
BlackRock
BlackRock
New York
+$3.05M

Top Sellers

1
Fidelity Investments
Fidelity Investments
Massachusetts
-$31.4M
2
BC
Boxer Capital
California
-$19.2M
3
VC
Vivo Capital
California
-$5.37M
4
JP Morgan Chase
JP Morgan Chase
New York
-$1.56M
5
Bank of New York Mellon
Bank of New York Mellon
New York
-$1.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
O
1
OrbiMed
New York
$44.2M – – –
FM
2
Frazier Management
Washington
$31.8M – – –
VVM
3
Versant Venture Management
California
$31.5M – – –
BlackRock
4
BlackRock
New York
$22.2M +$3.05M +18,677 +12%
DTC
5
Deep Track Capital
Connecticut
$20.4M +$26.3M +160,850 New
NLVP
6
New Leaf Venture Partners
New York
$15.9M – – –
Vanguard Group
7
Vanguard Group
Pennsylvania
$12.2M -$555K -3,398 -3%
WP
8
Woodline Partners
California
$12.2M +$13M +79,661 +495%
Fidelity Investments
9
Fidelity Investments
Massachusetts
$11.4M -$31.4M -192,026 -68%
Morgan Stanley
10
Morgan Stanley
New York
$9.86M +$3.34M +20,433 +36%
GPP
11
Great Point Partners
Connecticut
$9.64M +$12.4M +75,905 New
HCM
12
Highline Capital Management
New York
$7.85M +$408K +2,500 +4%
State Street
13
State Street
Massachusetts
$4.55M +$278K +1,701 +5%
Geode Capital Management
14
Geode Capital Management
Massachusetts
$4.27M +$1.62M +9,950 +42%
JP Morgan Chase
15
JP Morgan Chase
New York
$3.77M -$1.56M -9,557 -24%
EAM
16
Erste Asset Management
Austria
$3.34M +$4.37M +26,750 New
Renaissance Technologies
17
Renaissance Technologies
New York
$3.02M +$2.8M +17,120 +257%
Two Sigma Advisers
18
Two Sigma Advisers
New York
$2.74M +$2.22M +13,625 +172%
Two Sigma Investments
19
Two Sigma Investments
New York
$2.72M +$1.82M +11,148 +108%
WMSA
20
Weiss Multi-Strategy Advisers
New York
$2.42M +$367K +2,250 +13%
Northern Trust
21
Northern Trust
Illinois
$2.16M +$105K +645 +4%
Charles Schwab
22
Charles Schwab
California
$1.63M +$52.3K +320 +3%
N
23
Nuveen
North Carolina
$1.61M +$297K +1,818 +17%
Wellington Management Group
24
Wellington Management Group
Massachusetts
$1.51M -$1.5M -9,158 -43%
Millennium Management
25
Millennium Management
New York
$1.3M -$1.14M -6,976 -41%
1
2 3 4 5

PASG Hedge Fund Activity: Q4 2021 in Review

99 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Passage Bio (PASG) for Q4 2021, worth a combined $278M — down 34% from $419M a quarter earlier.

Sellers outnumbered buyers: 18 funds closed out of PASG and 17 opened new positions — a net loss of 1 holder — while 22 trimmed existing stakes and 41 added.

The largest buyer was Woodline Partners, adding an estimated $13M. The largest seller was Fidelity Investments, cutting an estimated $31.4M.

  • 99 institutional investors held Passage Bio (PASG) as of Q4 2021, down from 101 in Q3 2021.
  • Funds reported $278M of Passage Bio stock for Q4 2021, down 34% quarter-over-quarter.
  • 17 funds opened new Passage Bio positions in Q4 2021 and 18 closed out, a net change of -1 holder.
  • The largest Passage Bio buyer in Q4 2021 was Woodline Partners, an estimated $13M added.
  • The largest Passage Bio seller in Q4 2021 was Fidelity Investments, an estimated $31.4M sold.

Based on aggregated 13F filings for Q4 2021.